|
Fredun Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
746.66 Cr.
|
P/BV
|
5.71
|
Book Value (Rs.)
|
277.17
|
|
52 Week High/Low (Rs.)
|
1999/635
|
FV/ML
|
10/1
|
P/E(X)
|
35.88
|
|
Bookclosure
|
23/09/2025
|
EPS (Rs.)
|
44.07
|
Div Yield (%)
|
0.04
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 262.99 |
| Total Income From Operations | 262.99 |
| | |
| EXPENDITURE | |
| Consumption of Raw Materials | 191.52 |
| Increase/Decrease in Stocks | -2.25 |
| Employees Cost | 15.93 |
| Depreciation | 3.31 |
| Other Expenses | 20.62 |
| Total Expenses | 229.14 |
| | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 33.85 |
| Other Income | 2.16 |
| P/L Before Interest, Excpt. Items & Tax | 36.01 |
| Interest | 14.26 |
| P/L Before Exceptional Items & Tax | 21.75 |
| P/L Before Tax | 21.75 |
| Tax | 5.55 |
| P/L After Tax from Ordinary Activities | 16.20 |
| Net Profit/Loss For the Period | 16.20 |
| Net P/L After Minority Interest & Share Of Associates | 16.20 |
| | |
| Equity Share Capital | 4.72 |
| EPS Before Extra Ordinary * | |
| Basic EPS (Rs.) | 34.30 |
| Diluted EPS (Rs.) | 34.30 |
| EPS After Extra Ordinary * | |
| Basic EPS (Rs.) | 34.30 |
| Diluted EPS (Rs.) | 34.30 |
| | |
| PBITOE Margin (%) | 12.87 |
| PBTE Margin (%) | 8.26 |
| PBT Margin (%) | 8.26 |
| PAT Margin (%) | 6.15 |
| PAT After MI And SOA Margin (%) | 6.15 |
